HIV Protease Inhibitors
- Name
- HIV Protease Inhibitors
- Accession Number
- DBCAT000552
- Description
Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly.
- Drugs
Drug Drug Description Nelfinavir A viral protease inhibitor used in the treatment of HIV infection. Indinavir A protease inhibitor used to treat HIV infection. Ritonavir An HIV protease inhibitor used in combination with other antivirals in the treatment of HIV infection. Atazanavir An antiviral protease inhibitor used in combination with other antiretrovirals for the treatment of HIV. Saquinavir An HIV protease inhibitor used in combination with other antiretroviral agents for the treatment of HIV-1 with advanced immunodeficiency. Darunavir A HIV protease inhibitor used in the treatment of human immunodeficiency virus (HIV) infection in patients with history of prior antiretroviral therapies. Fosamprenavir An antiretroviral agent used for the treatment and postexposure prophylaxis of human immunodeficiency virus (HIV-1) infection. Amprenavir A protease inhibitor used to treat HIV infection. Lopinavir An HIV-1 protease inhibitor used in combination with ritonavir to treat human immunodeficiency virus (HIV) infection. Tipranavir A protease inhibitor used to treat HIV-1 resistant to more than 1 protease inhibitor. Asunaprevir An NS3 protease inhibitor used to treat hepatitis C genotype 1b. JE-2147 Not Available L-756423 Not Available TMC-310911 TMC-310911 (also known as ASC-09) is a novel investigational protease inhibitor (PI) that is structurally similar to the currently available darunavir. It is being investigated for use in HIV-1 infections.... - Drugs & Drug Targets